Yamin Khan
Directeur Général chez HVIVO PLC
Fortune : 174 092 $ au 31/05/2024
Profil
Mr. Yamin M.
Khan is a Chief Executive Officer & Director at hVIVO PLC and an EVP-Global Clinical Development at Pharm-Olam International Ltd.
He is on the Board of Directors at hVIVO PLC.
Mr. Khan was previously employed as a Chief Revenue Officer by Pharm-Olam International (UK) Ltd.
He received his undergraduate degree from The University of Liverpool and a doctorate degree from The University of Southampton.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HVIVO PLC
0,07% | 31/12/2022 | 510 204 ( 0,07% ) | 174 092 $ | 31/05/2024 |
Postes actifs de Yamin Khan
| Sociétés | Poste | Début |
|---|---|---|
| HVIVO PLC | Directeur Général | 24/02/2022 |
Pharm-Olam International Ltd.
 Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | Corporate Officer/Principal | 11/11/2009 |
Anciens postes connus de Yamin Khan
| Sociétés | Poste | Fin |
|---|---|---|
Pharm-Olam International (UK) Ltd.
 Pharm-Olam International (UK) Ltd. BiotechnologyHealth Technology Part of Shomer XV Ltd., Pharm-Olam International (UK) Ltd. is a clinical research organization that specializes in solving distinct challenges of small and mid-sized biopharma companies. The company is based in Bracknell, UK and operates under the name allucent. The British company offers contract research services and clinical expertise to ensure the success of their clients' products. The company's resource center provides the latest articles, blogs, brochures, and videos from their experts. | Corporate Officer/Principal | 01/01/2019 |
Formation de Yamin Khan
| The University of Liverpool | Undergraduate Degree |
| The University of Southampton | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HVIVO PLC | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | Commercial Services |
Pharm-Olam International (UK) Ltd.
Pharm-Olam International (UK) Ltd. BiotechnologyHealth Technology Part of Shomer XV Ltd., Pharm-Olam International (UK) Ltd. is a clinical research organization that specializes in solving distinct challenges of small and mid-sized biopharma companies. The company is based in Bracknell, UK and operates under the name allucent. The British company offers contract research services and clinical expertise to ensure the success of their clients' products. The company's resource center provides the latest articles, blogs, brochures, and videos from their experts. | Health Technology |
